Inventor
HEMEON IVAN WILLIAM
CA17 patents
⚠️ This page may combine multiple inventors who share the name “HEMEON IVAN WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
16 patentsUS8933236B2Jan 13, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC50 citations97
US8952169B2Feb 10, 2015
N-substituted benzamides and methods of use thereof
GENENTECH INC25 citations92
US9771376B2Sep 26, 2017
N-substituted benzamides and methods of use thereof
GENENTECH INC7 citations84
US10005724B2Jun 26, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC6 citations83
US9694002B2Jul 4, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC11 citations83
US9546164B2Jan 17, 2017
Substituted benzamides and methods of use thereof
GENENTECH INC13 citations83
US10526285B2Jan 7, 2020
Therapeutic compounds and methods of use thereof
GENENTECH INC1 citations72
US10125098B2Nov 13, 2018
Therapeutic compounds and methods of use thereof
GENENTECH INC2 citations72
US9550775B2Jan 24, 2017
Substituted triazolopyridines and methods of use thereof
GENENTECH INC7 citations72
US11203572B2Dec 21, 2021
Substituted benzamides and methods of use thereof
GENENTECH INC0 citations62
US10766858B2Sep 8, 2020
Substituted benzamides and methods of use thereof
GENENTECH INC1 citations62
US11149002B2Oct 19, 2021
Therapeutic compounds and methods of use thereof
GENENTECH INC0 citations61
US10071957B2Sep 11, 2018
N-substituted benzamides and methods of use thereof
GENENTECH INC1 citations52
US10179767B2Jan 15, 2019
Substituted benzamides and methods of use thereof
GENENTECH INC0 citations51
US11130726B2Sep 28, 2021
Therapeutic compounds and methods of use thereof
GENENTECH INC0 citations49
US10899732B2Jan 26, 2021
Substituted benzamides useful as sodium channel blockers
GENENTECH INC0 citations48